The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Iron oxide and gold bimetallic radiosensitizers for synchronous tumor chemoradiation therapy in 4T1 breast cancer murine model
Abstract
The development of highly integrated multifunctional nanomaterials with a superadditive therapeutic effect and good safety is an urgent but challenging task in cancer therapy research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the Fe3O4–Au bimetallic system included in the present review [80] combined magnetic iron oxide and gold nanoparticles as a multifunctional platform for targeted chemoradiotherapy in 4T1 breast cancer models.”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [80]
In the citing paper
“Combined treatment was associated with greater tumor growth delay or regression compared to radiotherapy alone [17,20,39,40,43,50,63,80].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [80]
In the citing paper
“Prolonged survival or improved overall survival was described in combined treatment groups compared to controls [17,36,43,53,80].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [80]
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Greczynski, G., & Hultman, L. (2017) · ChemPhysChem · doi:10.1002/cphc.201700126 · Cited by 1,063
Palma, D. A., Senan, S., Tsujino, K., Barriger, R. B., Rengan, R., Moreno, M., Bradley, J. D., Kim, T. H., Ramella, S., Marks, L. B., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.04.043 · Cited by 674
Gold nanoparticles for cancer radiotherapy: a review
Haume, K., Rosa, S., Grellet, S., Śmiałek, M. A., Butterworth, K. T., Solov’yov, A. V., Prise, K. M., Golding, J., & Mason, N. J. (2016) · Cancer Nanotechnology · doi:10.1186/s12645-016-0021-x · Cited by 445
Yong, Y., Cheng, X., Bao, T., Zu, M., Yan, L., Yin, W., Ge, C., Wang, D., Gu, Z., & Zhao, Y. (2015) · ACS Nano · doi:10.1021/acsnano.5b05825 · Cited by 435
Emerging Strategies of Nanomaterial‐Mediated Tumor Radiosensitization
Xie, J., Gong, L., Zhu, S., Yong, Y., Gu, Z., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201802244 · Cited by 415
Research works printed but not linked: 2
- Kwatra, 2013, Transl. Cancer Res., 2, 330
- Nosrati, 2020, Biomater. Sci., 8, 4275, 10.1039/d0bm00353k · DOI
Cited by
Pan, Y., Tang, W., Fan, W., Zhang, J., & Chen, X. S. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01145f · Cited by 131
Multifunctional nanoparticle for cancer therapy
Gao, Y., Wang, K., Zhang, J. C., Duan, X., Sun, Q., & Men, K. (2023) · MedComm · doi:10.1002/mco2.187 · Cited by 97
Nosrati, H., Seidi, F., Hosseinmirzaei, A., Mousazadeh, N., Mohammadi, A., Ghaffarlou, M., Danafar, H., Conde, J., & Sharafi, A. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202102321 · Cited by 68
Self-citationNosrati, H., Ghaffarlou, M., Salehiabar, M., Mousazadeh, N., Abhari, F., Barsbay, M., Ertas, Y. N., Rashidzadeh, H., Mohammadi, A., Nasehi, L., et al. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213090 · Cited by 60
Self-citationTargeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapy
Salehiabar, M., Ghaffarlou, M., Mohammadi, A., Mousazadeh, N., Rahimi, H., Abhari, F., Rashidzadeh, H., Nasehi, L., Rezaeejam, H., Barsbay, M., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.004 · Cited by 56
Self-citation
Metadata
- Authors
- Nosrati, H., Baghdadchi, Y., Abbasi, R., Barsbay, M., Ghaffarlou, M., Abhari, F., Mohammadi, A., Kavetskyy, T., Bochani, S., Rezaeejam, H., Davaran, S., & Danafar, H.
- Affiliations
- Zanjan University of Medical Sciences (IR)
- University of Zanjan (IR)
- Hacettepe University (TR)
- John Paul II Catholic University of Lublin (PL)
- Tabriz University of Medical Sciences (IR)
- Corresponding author
- Nosrati, Hamed
- Danafar, Hossein
- ORCID
- Venue
- Journal of Materials Chemistry B
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 9
- Issue
- 22
- Pages
- 4510-4522
- ISSN
- 2050-750X (ISSN-L)
- 2050-7518
- OpenAlex
- W3164427669
- Cited by
- 37
- References
- 45
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 10 · 2022: 12 · 2021: 1
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Materials Chemistry B (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Zanjan University of Medical Sciences (A-12-430-38)
- Türkiye Bilimsel ve Teknolojik Araştirma Kurumu (217Z069)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- bimetallic nanoparticles, radiosensitizers, chemoradiotherapy, breast cancer, 4T1 cells, curcumin, folic acid targeting, bovine serum albumin coating, reactive oxygen species, DNA damage
- MeSH terms
- Animals, Breast Neoplasms, Ferric Compounds, Gold, Radiation-Sensitizing Agents, Cell Line, Tumor, Mice, Chemoradiotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Iron oxide and gold bimetallic radiosensitizers for synchronous tumor chemoradiation therapy in 4T1 breast cancer murine model. https://app.cochat.ai/papers/10.1039/d0tb02561e
- The paper
- Nosrati, H., Baghdadchi, Y., Abbasi, R., Barsbay, M., Ghaffarlou, M., Abhari, F., Mohammadi, A., Kavetskyy, T., Bochani, S., Rezaeejam, H., Davaran, S., & Danafar, H. (2021). Iron oxide and gold bimetallic radiosensitizers for synchronous tumor chemoradiation therapy in 4T1 breast cancer murine model. Journal of Materials Chemistry B. https://doi.org/10.1039/d0tb02561e
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.